Short Term Indicators 7 Day Average Directional Indicator Buy 10 - 8 Day Moving Average Hilo Channel Buy 20 Day Moving Average vs Price Buy 20 - 50 Day MACD Oscillator Sell 20 Day Bollinger Bands Buy
Short Term Indicators Average: 60% - Buy 20-Day Average Volume - 1516735
Medium Term Indicators 40 Day Commodity Channel Index Buy 50 Day Moving Average vs Price Buy 20 - 100 Day MACD Oscillator Sell 50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 50% - Buy 50-Day Average Volume - 847360
Long Term Indicators 60 Day Commodity Channel Index Buy 100 Day Moving Average vs Price Buy 50 - 100 Day MACD Oscillator Sell
Long Term Indicators Average: 33% - Buy 100-Day Average Volume - 564454
the same screener it popped on typically shows 30 to 40 stocks at any given time....
they may or may not get involved in the tsunami cleanup--- i WAS thinking it is pure speculation on that(tsunami money)..we'll see if there really is some MORE news coming in..they just had news on the 28th
posted
BUGS CEO Foresees Prosperous 2005 Monday January 10, 9:25 am ET Company to Exploit Opportunities Identified in 2004
CARLSBAD, Calif.--(BUSINESS WIRE)--Jan. 10, 2005--Robert Brehm, CEO of U.S. Microbics, Inc., (OTCBB:BUGS - News) today announced that he foresees a prosperous business year in 2005 based upon recent developments in new business, the revenue potential of new joint ventures and alliances, anticipated acquisitions, institutional financing, and a favorable U.S. economic outlook. The company is also building upon many of the opportunities identified in 2004 that are now starting to generate revenue. The company's strategic objective is to increase gross revenues to $5,000,000 - $10,000,000 in 2005 by ramping-up joint ventures operations, increasing environmental cleanup revenues, adding new business divisions, and acquiring synergistic businesses.
With the technology demonstration groundwork completed and opportunities identified in 2004 now coming online with revenue, BUGS has positioned itself for tremendous growth in 2005. Through the direction of Mr. Brehm, who received the 2003 California Businessman of the Year Award as well as the 2004 Ronald Reagan Republican Gold Metal Award, BUGS, and its operating subsidiaries, have entered into various joint ventures with strategic partners who can provide marketing, financial and tactical resources which augment the BUGS engineering and biotech capability to deploy the proprietary biotechnology to domestic and international clients. Should the company successfully execute its strategic objectives, BUGS could have a record year in terms of financial results and shareholder value.
Mr. Brehm commented, "We made major progress in 2004 with technology demonstrations for environmental cleanup of rocket fuel (perchlorates), new joint ventures in the diesel to natural gas conversion technology and water machines for third world countries, recognition of the merits of our technology by Mexico government authorities, introduction of the Mikey Microbe(TM) educational character at www.mikeymicrobe.com and new business for USM Capital Group, Inc., our financial services subsidiary. Our merger and acquisition team was also very active performing due diligence on candidates in the $2,000,000 to $60,000,000 revenue range. All these activities prepared us for new revenue sources and success in 2005."
Brehm went on to say, "To help the investment community understand the company's direction I have included key elements of our strategic plan in this press release. I expect to implement as much of this plan as possible given the available capital, market opportunities and resources available. 2005 could be a very exciting and prosperous year and I look forward to leading BUGS to new levels of success."
Key elements of the 2005 Strategic Plan include:
1. New environmental cleanup business for Sub-Surface Waste Management, Inc. These projects include new contract work in Mexico, rocket fuel cleanup in California, completion of projects in South Carolina, new cleanup projects with JV/teaming partners, and engineering consulting for water machine projects.
2. Acquisition of one or more profitable $2MM to $5MM revenue firms to increase our engineering capability to manage multi-million dollar projects.
3. Generate revenue for the Natural Gas Industries and World Wide Water Systems joint ventures with Omnitek and C. Trade, Inc.
4. Provide additional financial and administrative services to the joint ventures and third party clients through USM Capital Group, Inc.
5. Expand the educational services and marketing of the Mikey Microbe character and products to include internet sales of environmentally friendly products.
6. Use Institutional investor funds and cash flow to grow the business and increase the financial well being of the company.
Brehm concluded by saying, "We've already begun to see the revenue results of our 2005 strategic plan and will update the investment community as we accomplish additional milestones. I am truly excited about 2005 and the opportunities before us. As always I appreciate the support and continued shareholder trust in management and the future of U.S. Microbics, Inc. and its subsidiaries."
About U.S. Microbics Inc.
U.S. Microbics is a business development and holding company that acquires, develops and deploys innovative environmental technologies for soil, groundwater and carbon remediation, air pollution reduction, modular drinking water systems, and agriculture enhancement. For more information on the company contact Robert Brehm at 760-918-1860 x102 or visit the website at http://bugsatwork.com. To join the company's mailing list, please send your name and email address to investor@bugsatwork.com.
About Sub-Surface Waste Management
A subsidiary of U.S. Microbics, Inc., (OTCBB: BUGS - News), Sub-Surface Waste Management Inc. provides comprehensive civil and environmental engineering project management services including specialists to design, permit, build and operate environmental waste clean-up treatment systems using conventional, biological and filtration technologies. SSWM is capitalizing on its patent and patent-pending technology by forming strategic alliances and joint ventures with well-established engineering firms.
About USM Capital Group Inc.
USM Capital Group Inc. (UCGI) is the financial services subsidiary of U.S. Microbics Inc. The UCGI mission is to provide financial resources and services to private and publicly traded companies. For further information about U.S. Microbics or USM Capital Group, contact Robert Brehm by phone at 760-918-1860, ext. 102 or learn about the company by visiting the Web site at http://www.usmcapital.com.
The information contained in this press release includes forward-looking statements. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect" or similar expressions that involve risks and uncertainties. These risks and uncertainties include the company's status as a startup company with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments and protection of its intellectual property. The company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the "Risk Factors," "Management's Discussion and Analysis or Plan of Operation" and other sections of the company's Form 10-KSB and other publicly available information regarding the company on file with the Securities and Exchange Commission. The company will provide you with copies of this information upon request.
-------------------------------------------------------------------------------- Contact: U.S. Microbics Inc. Robert Brehm at 760-918-1860, Ext. 102 http://bugsatwork.com
-------------------------------------------------------------------------------- Source: Microbics, Inc.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
